Gonzalez-Lopez, Julio J.
Arruza Santos, Maria E.
Leon Garcia, Jorge
Funding for this research was provided by:
Alcon (MWG#76035373)
Article History
Received: 7 March 2023
Accepted: 27 September 2023
First Online: 18 October 2023
Declarations
:
: JJGL has been co-investigator for Hoffmann-La Roche AG and Gyroscope Therapeutics Ltd, holds stock of Gilead, has received research grants from Alcon, and study grants from Abbvie, Bayer, Novartis and Thea. The rest of the authors declare no conflicts of interest.
: The study protocol, number 104/22, was approved by the Research Ethics Committee of the Ramón y Cajal University Hospital and all research complied with the tenets of the declaration of Helsinki. Given the retrospective retrieval of data, the requirement for consent was waived by the ethics committee.